Could a probiotic ease your aching joints?
NCT ID NCT06658821
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a daily capsule containing a heat-killed probiotic (LDL557) can improve joint discomfort and inflammation in 100 older adults with early knee or hip arthritis. Participants take either the probiotic or a placebo for a period, and researchers measure changes in pain, stiffness, and daily function using standard arthritis questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LDL557-HK capsule (heat-killed Lactobacillus delbrueckii subsp. lactis LDL557)
- What this could lead to
- If it works, this could offer a natural, drug-free option to reduce joint pain and stiffness in early arthritis.
- What could go wrong
- This is a small, early-stage trial with no blinding details. The supplement may not outperform placebo, and results may not apply to more severe arthritis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chung Shan Medical University
Taichung, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Can a diabetes drug improve joint replacement outcomes?
- Could a daily supplement combo ease joint pain and fatigue in midlife women?
- Could a daily supplement ease joint pain, fatigue, and sleep troubles in middle age?
- Can a new Slow-Release ibuprofen tame knee arthritis pain for 12 hours?
- A short therapy program may help workers with arthritis keep their jobs — a trial puts it to the test